Table 3 Differentially expressed proteins and unique proteins commonly quantified in FFPE and OCT preserved samples (T2/T3 vs Ta/T1) and their relevance in cancer research.

From: Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer

Protein ID

Protein name

Gene name

FFPE (T2/T3 vs Ta/T1)

OCT (T2/T3 vs Ta/T1)

Cancer relevance

Ref

Log2 fold change

P-value

Log2 fold change

P-value

P09382

Galectin-1

LGALS1

2.18

0.019

1.42

0.004

Angiogenesis, invasion, cell–cell and cell–matrix interactions important for metastasis

11,37

P08758

Annexin A5

ANXA5

1.39

0.001

0.95

0.001

Tumor progression, invasion, metastasis, drug resistance

12,13

P31930

Cytochrome b-c1 complex subunit 1, mitochondrial

UQCRC1

− 0.73

0.001

− 1.02

0.017

Highly expressed in breast and ovarian tumors

38

Q96I99

Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial

SUCLG2

− 0.77

0.034

− 1.57

0.030

Decreased expression in renal carcinoma

39

P38117

Electron transfer flavoprotein subunit beta

ETFB

− 0.81

0.026

− 1.43

0.017

Biomarker of follicular carcinoma

40

P39687

Acidic leucine-rich nuclear phosphoprotein 32 family member A

ANP32A

− 0.92

0.035

− 1.03

0.017

Promotes colorectal cancer proliferation

41

P51532

Transcription activator BRG1

SMARCA4

− 1.37

0.010

− 0.71

0.038

Tumor suppressor

42

P49411

Elongation factor Tu, mitochondrial

TUFM

− 1.20

0.039

− 1.03

0.035

Bad prognosis in colorectal and lung cancer

14,15

P54868

Hydroxymethylglutaryl-CoA synthase, mitochondrial

HMGCS2

Unique in Ta/T1

Unique in Ta/T1

Prognosis biomarker in several cancer tissues

16,17,18,19

  1. Deregulated proteins are emphasised (bold—upregulated, italics—downregulated).